Literature DB >> 19359705

Relationship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis.

Kasey C Vickers1, Colin T Maguire, Robert Wolfert, Alan R Burns, Michael Reardon, Richard Geis, Paul Holvoet, Joel D Morrisett.   

Abstract

Plasma levels of lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and oxidized low density lipoprotein (oxLDL) have been identified as risk factors for cardiovascular disease. Lp-PLA(2) is the sole enzyme responsible for the hydrolysis of oxidized phospholipids on LDL particles in atherosclerotic plaques. We have studied the relationship between Lp-PLA(2) and oxLDL in carotid endarterectomy (CEA) tissues and in matched plasmas. In extracts from CEA anatomical segments, the levels of oxLDL were significantly associated with the levels of Lp-PLA(2) protein (r = 0.497) and activity (r = 0.615). OxLDL and Lp-PLA(2) mass/activity were most abundant in the carotid bifurcation and internal segments where plaque was most abundant. In extracts from CEA atheroma, the levels of oxLDL and Lp-PLA(2) were significantly correlated (r = 0.634). In matched plasma and atheroma extracts, the levels of Lp-PLA(2) were negatively correlated (r = - 0.578). The ratio of Lp-PLA(2) to oxLDL was higher in atheromatous tissue (277:1) than in normal tissue (135:1) and plasma (13:1). Immunohistochemical experiments indicated that in plaques, oxLDL and Lp-PLA(2) existed in overlapping but distinctly different distribution. Fluorescence microscopy showed both oxLDL and Lp-PLA(2) epitopes on the same LDL particle in plasma but not in plaque. These results suggest that the relationship between Lp-PLA(2) and oxLDL in the atherosclerotic plaque is different from that in the plasma compartment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19359705      PMCID: PMC2724786          DOI: 10.1194/jlr.M800342-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  41 in total

1.  Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions.

Authors:  T Häkkinen; J S Luoma; M O Hiltunen; C H Macphee; K J Milliner; L Patel; S Q Rice; D G Tew; K Karkola; S Ylä-Herttuala
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-12       Impact factor: 8.311

Review 2.  Linking inflammation and atherogenesis: Soluble markers identified for the detection of risk factors and for early risk assessment.

Authors:  James T Wu; Lily L Wu
Journal:  Clin Chim Acta       Date:  2005-12-15       Impact factor: 3.786

Review 3.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 4.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

Review 5.  Phospholipase A2 enzymes.

Authors:  Ichiro Kudo; Makoto Murakami
Journal:  Prostaglandins Other Lipid Mediat       Date:  2002-08       Impact factor: 3.072

6.  Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis.

Authors:  Frank D Kolodgie; Allen P Burke; Kristi S Skorija; Elena Ladich; Robert Kutys; Addisalem Taye Makuria; Renu Virmani
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-09-07       Impact factor: 8.311

Review 7.  Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review.

Authors:  Carolina A Garza; Victor M Montori; Joseph P McConnell; Virend K Somers; Iftikhar J Kullo; Francisco Lopez-Jimenez
Journal:  Mayo Clin Proc       Date:  2007-02       Impact factor: 7.616

8.  Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.

Authors:  C J Packard; D S O'Reilly; M J Caslake; A D McMahon; I Ford; J Cooney; C H Macphee; K E Suckling; M Krishna; F E Wilkinson; A Rumley; G D Lowe
Journal:  N Engl J Med       Date:  2000-10-19       Impact factor: 91.245

9.  Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein.

Authors:  D M Stafforini; L W Tjoelker; S P McCormick; D Vaitkus; T M McIntyre; P W Gray; S G Young; S M Prescott
Journal:  J Biol Chem       Date:  1999-03-12       Impact factor: 5.157

10.  An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma.

Authors:  K E Stremler; D M Stafforini; S M Prescott; G A Zimmerman; T M McIntyre
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

View more
  16 in total

1.  Determination of phospholipase activity of PAF acetylhydrolase.

Authors:  Diana M Stafforini; Thomas M McIntyre
Journal:  Free Radic Biol Med       Date:  2012-05-29       Impact factor: 7.376

Review 2.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

3.  Lipoprotein-associated phospholipase A2 is associated with postpartum hypertension in women with history of preeclampsia.

Authors:  Yuheng Zhou; Jianmin Niu; Dongmei Duan; Qiong Lei; Jiying Wen; Xiaohong Lin; Lijuan Lv; Longding Chen
Journal:  Heart Vessels       Date:  2014-04-23       Impact factor: 2.037

Review 4.  Lipid Abnormalities and Inflammation in HIV Inflection.

Authors:  Nicholas T Funderburg; Nehal N Mehta
Journal:  Curr HIV/AIDS Rep       Date:  2016-08       Impact factor: 5.071

5.  Morphometric analysis of calcification and fibrous layer thickness in carotid endarterectomy tissues.

Authors:  Richard I Han; Thomas M Wheeler; Alan B Lumsden; Michael J Reardon; Gerald M Lawrie; K Jane Grande-Allen; Joel D Morrisett; Gerd Brunner
Journal:  Comput Biol Med       Date:  2016-01-22       Impact factor: 4.589

6.  Omega-3 fatty acids and lipoprotein associated phospholipase A(2) in healthy older adult males and females.

Authors:  T L Nelson; J E Hokanson; M S Hickey
Journal:  Eur J Nutr       Date:  2010-08-13       Impact factor: 5.614

7.  Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk.

Authors:  Kenneth J Colley; Robert L Wolfert; Michael E Cobble
Journal:  EPMA J       Date:  2011-03-10       Impact factor: 6.543

8.  Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis.

Authors:  Hui-Ping Gong; Yi-Meng Du; Li-Na Zhong; Zhao-Qiang Dong; Xin Wang; Yong-Jun Mao; Qing-Hua Lu
Journal:  Lipids Health Dis       Date:  2011-01-19       Impact factor: 3.876

9.  Lipidomic analysis of human plasma reveals ether-linked lipids that are elevated in morbidly obese humans compared to lean.

Authors:  Elise L Donovan; Stefan M Pettine; Matthew S Hickey; Karyn L Hamilton; Benjamin F Miller
Journal:  Diabetol Metab Syndr       Date:  2013-05-14       Impact factor: 3.320

10.  Localization of oxidized low-density lipoprotein and its relation to plaque morphology in human coronary artery.

Authors:  Yasumi Uchida; Yuko Maezawa; Yasuto Uchida; Nobuyuki Hiruta; Ei Shimoyama; Seiji Kawai
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.